You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies

Full name:
anti-Kallikrein B, Plasma 1 Antibodies (KLKB1)
On www.antibodies-online.com are 19 Kallikrein B, Plasma 1 (KLKB1) Antibodies from 3 different suppliers available. A total of 21 Kallikrein B, Plasma 1 products are currently listed.
Synonyms:
Aps, hK3, Kal-3, Kal3, Kalp1, KALP15, KLK2A1, Klk3, PSA
list all antibodies Gene Name GeneID UniProt
KLKB1 16621 P26262
KLKB1 25048  
KLKB1 354 P07288

Show all species

Show all synonyms

Most Popular Reactivities for anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

anti-Human Antibodies:

All available anti-Kallikrein B, Plasma 1 Antibodies

Go to our pre-filtered search.

More Antibodies against Kallikrein B, Plasma 1 Interaction Partners

Mouse (Murine) Kallikrein B, Plasma 1 (KLKB1) interaction partners

  1. we found that post-ejaculated semen from fertile wild-type males was solidified and the sperm were entrapped in Wnt7aCre/+;Esr1f/f uteri, compared to the watery semen (liquefied) found in Esr1f/f controls.Kallikrein-related peptidases 3 (KLK3 (show PSA Antibodies)) and other kallikrein (show KLK1 Antibodies)-related peptidases from male prostate glands are responsible for semen liquefaction by cleaving gel-forming proteins

  2. Klkb1(-/-) mice have a novel mechanism for thrombosis protection in addition to reduced contact activation. This pathway arises when bradykinin delivery to vasculature is compromised and mediated by increased receptor Mas (show MAS1 Antibodies), prostacyclin, Sirt1 (show SIRT1 Antibodies), and KLF4 (show KLF4 Antibodies)

  3. Plasma kallikrein deletion prevents occlusive thrombus formation in mice with a minimal role in provoked bleeding.

  4. PKK (show RIPK4 Antibodies) or fXII (show F12 Antibodies) deficiency reduced thrombus formation in both arterial and venous thrombosis models, without an apparent effect on hemostasis.

  5. Data suggest that LGG secreting PSA (show NPEPPS Antibodies) may activate antigen specific immune responses when instilled intravesically and IL15 (show IL15 Antibodies) could enhance this response.

  6. the prekallikrein gene (Klkb1) is expressed highly in the mammary gland during stromal remodeling periods including puberty and postlactational involution.

Human Kallikrein B, Plasma 1 (KLKB1) interaction partners

  1. Extended follow-up of the PLCO trial over a median of 15 years continues to indicate no reduction in prostate cancer mortality for the intervention arm versus the control arm. Because of the high rate of control-arm PSA (show PLAG1 Antibodies) testing, this finding can be viewed as showing no benefit of organized screening versus opportunistic screening

  2. Data indicate that prostate specific antigen (PSA (show KLK3 Antibodies)) is a negative predictive biomarker for local recurrence during follow-up.

  3. The prostate-specific antigen (show KLK3 Antibodies) density (PSAD) cutoff level generated for Nigerian men in this study is 0.04 which is relatively different from international consensus. This PSAD cutoff level has a positive correlation with histology and could detect patients with prostate cancer who have "grey zone PSA (show PLAG1 Antibodies)."

  4. In conclusion, serum levels of BSP (show KLK6 Antibodies), ALP (show ALP Antibodies), ICTP, and PSA (show PLAG1 Antibodies) increased in patients with bone metastases, and combined detection of all markers could improve the positive-predictive value.

  5. The combined efficacies of whole-body magnetic resonance imaging, bone scintigraphy and PSA (show PLAG1 Antibodies) levels were desired in identifying prostate cancer lesions and prognosis.

  6. A combination of high preoperative serum PSA (show PLAG1 Antibodies) and high expression of TMPRSS2 (show TMPRSS2 Antibodies)-ERG (show ERG Antibodies) could be promising in distinguishing those tumors that are aggressive and life-threatening.

  7. Higher miR (show MLXIP Antibodies)-139-5p expression in prostate cancer patients was observed to be associated with certain clinicopathological parameters, including PSA (show PLAG1 Antibodies) greater than 20ng/ml, pathological tumor stage, and Gleason score.

  8. PSA (show PLAG1 Antibodies) velocity can be more predictive after surgery and PSA (show PLAG1 Antibodies) doubling time can be more predictive after radiation therapy.

  9. Salvage radiotherapy conferred better prostate cancer control when administered at the very first sign of PSA (show PLAG1 Antibodies) rise.

  10. Dynamic changes of ALP (show ALP Antibodies), LDH and PSA (show PLAG1 Antibodies) during Abiraterone-therapy are associated with best clinical benefit and OS in bone metastatic castration resistant prostate cancer

Kallikrein B, Plasma 1 (KLKB1) Antigen Profile

Antigen Summary

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its protein product is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. Serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms.

Alternative names and synonyms associated with Kallikrein B, Plasma 1 (KLKB1)

  • kallikrein B, plasma 1 (Klkb1) antibody
  • kallikrein-related peptidase 3 (KLK3) antibody
  • SH2B adaptor protein 2 (Sh2b2) antibody
  • Aps antibody
  • hK3 antibody
  • Kal-3 antibody
  • Kal3 antibody
  • Kalp1 antibody
  • KALP15 antibody
  • KLK2A1 antibody
  • Klk3 antibody
  • PSA antibody

Protein level used designations for KLKB1

antigen, prostate specific , fletcher factor , kallikrein 3, plasma , kininogenin , plasma kallikrein , plasma prekallikrein , P-30 antigen , gamma-seminoprotein , kallikrein-3 , prostate specific antigen , prostate-specific antigen , semenogelase , seminin , SH2 and PH domain-containing adapter protein APS , SH2B adapter protein 2 , adapter protein with pleckstrin homology and Src homology 2 domains , adaptor protein with pleckstrin homology and src homology 2 domains

GENE ID SPECIES
16621 Mus musculus
25048 Rattus norvegicus
354 Homo sapiens
114203 Rattus norvegicus
Selected quality suppliers for anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies
Did you look for something else?